rhBMP -12/absorbable collagen sponge is a safe & feasible adjuvant for rotator cuff repair .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Local rhBMP-12 on an Absorbable Collagen Sponge as an Adjuvant Therapy for Rotator Cuff Repair- A Phase 1, Randomized, Standard of Care Control, Multicenter Study: Part 1. Safety and Feasibility
Am J Sports Med. 2015 Jun 1. pii: 036354651558475620 patients with full-thickness rotator cuff tears were randomized to either a standard care treatment or 0.015mg/mL rhBMP-12/ACS along with standard care treatment during open rotator cuff repair to assess the safety and feasibility of recombinant human bone morphogenetic protein-12 (rhBMP-12) on an absorbable collagen sponge (ACS) as an adjuvant. Patients were followed for 52 weeks postoperatively. Findings indicated that rhBMP-12/ACS was a safe and feasible option for open rotator cuff repair when used at a concentration of 0.015 mg/mL.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
